milrinone and endothelin-1

milrinone has been researched along with endothelin-1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, GW; Yang, CQ1
Bjerkås, H; Helle, KB; Lønning, K1
Aardal, S; Helle, KB; Lillestłl, IK1

Other Studies

3 other study(ies) available for milrinone and endothelin-1

ArticleYear
Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Arteries; Cardiovascular Agents; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents

1996
The adrenomedullary venous vasculature as a target for endothelins: comparison of the porcine and bovine central adrenomedullary veins.
    Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 1998, Volume: 120, Issue:3

    Topics: Acetylcholine; Adenylyl Cyclases; Adrenal Medulla; Animals; Caffeine; Cattle; Colforsin; Cyclic AMP; Endothelin-1; Milrinone; Muscle, Smooth, Vascular; Neuropeptide Y; Potassium; Propranolol; Receptor, Endothelin A; Receptors, Endothelin; Second Messenger Systems; Species Specificity; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Veins

1998
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
    Scandinavian journal of clinical and laboratory investigation, 1998, Volume: 58, Issue:8

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids

1998